Bansalao, Rizamae A.

HRN: 29-14-55  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2026
CEFTAZIDIME 1GM (VIAL)
06/28/2026
07/05/2026
IV
2g
Q8
Febrile Neutropenia
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines